Tuesday, 9 November 2021 to Wednesday, 10 November 2021

Speakers

Dr Trevor Askwith
Domainex
Dr Martin Bachman
Medicines Discovery Catapult
Ms Sharon Barnard
INTEGRA Biosciences
Perdita Barran
University of Manchester
Dr Kristian Birchall
LifeArc
Adam Bond
Centre for Targeted Protein Degradation (CeTPD), University of Dundee
Jacob Bush
GlaxoSmithKline
Prof Neil Carragher
University of Edinburgh
Dr Stephanie Constantinou
AstraZeneca
Dr Peter Coombs
LifeArc
David Cronk
Domainex Ltd
Dr Jayme Dahlin
National Center for Advancing Translational Science (NCATS)
United States
Mrs Kathy Dodgson
Aurelia Bioscience Ltd
Miss Elaine Duncan
Charles River
Gareth Griffiths
Imagen Therapeutics
Dr Sarah Hewitt
AstraZeneca
Markus Hierl
Hoffmann La Roche
Switzerland
Mr Geoff Holdgate
AstraZeneca
Dr Finn Holding
Astrazeneca
Dr Vasudev Kantae
AstraZeneca
Dr Aarti Kawatkar
AstraZeneca
United States
Miss Tamsin Lamont
Collaborative Drug Discovery
Kath Mackay
Scott Maidment
Charles River
Dr Martin Main
Medicines Discovery Catapult
Dr Craig Malcolm
Promega UK Ltd
Paula A. Marin-Zapata
Bayer
Germany
Sarah Martin
Charles River
Dr Stuart McElroy
BioAscent Discovery ltd.
Dr Rachel Moore
AstraZeneca
Stephen Neidle
UCL School of Pharmacy
Dr Emily Offer
Medicines Discovery Catapult
Mr Renaud Prudent
EDELRIS
France
Simon Richards
Exscientia
Dr Roman Simon
Boehringer Ingelheim Pharma GmbH & Co. KG
Jonathan Stone
Benchling
Alexandra Stowell
Sygnature Discovery
Steven Trim
Venomtech Ltd
Prof Matthias Trost
Newcastle University
Kirsten Tschapalda
Roche
Dr Steven van Helden
Pivot Park Screening Centre
Netherlands
Dr Graeme Walker
Sygnature Discovery
Jarrod Walsh
AstraZeneca
Dr Kirsty Winn
Medicines Discovery Catapult
Dr Jana Wolf
Domainex